[8]
It may be that Novopharm is, in these circumstances, entitled to issue a fresh notice correcting the initial flaw. If that be the case, the regulatory clock will again begin to run its course. This is a question which the Court of Appeal will eventually decide. But, having regard to the totally new and distinct ground which Novopharm now wants to assert, the absence of any reasonable excuse for not bringing it forth at the appropriate stage, the entitlement of the first person to be made aware of the case which it has to meet from the onset, and the expedited nature of the proceedings under the
Regulations
, I decline to exercise my discretion in favour of the applicant.